PITTSFIELD, Mass — Following guidance from the federal Centers for Disease Control (CDC), Berkshire Health Systems will discontinue widespread distribution of the Johnson & Johnson (J&J) COVID-19 vaccines and boosters at its testing and vaccine centers, effective Jan. 6, 2022.

 

"This decision is based on guidance from the CDC, which recently examined the efficacy, safety, and supply of the J&J vaccine," said James Lederer, MD, BHS Chief Medical Officer/Chief Quality Officer.

 

"In light of these recommendations, the CDC has made it clear that getting any vaccine is far better than remaining unvaccinated. Any patient who would like to request an initial or booster dose of the J&J vaccine, despite known limitations and risks, can call the COVID-19 Hotline to consult with a provider," he explained.

 

Anyone who is currently scheduled for a J&J vaccine or booster at a BHS Testing and Vaccine Center on or before Jan 5 will have the option to receive the J&J vaccine as scheduled or can receive a Pfizer or Moderna dose instead.

 

"For individuals who have received one shot of the J&J vaccine, we highly recommend getting a Pfizer or Moderna booster. If they have already received a J&J booster, we are asking them to talk to their primary care provider about receiving a booster dose of one of the other available vaccines," said Dr. Lederer.

 

The BHS COVID-19 hotline is 855-BMC-LINK (855-262-5465). For more information on the CDC's decision, please visit their website: https://www.cdc.gov/media/releases/2021/s1216-covid-19-vaccines.html